[Study results of routine clinical practice. Do rheumatism patients get substandard care?].
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D005858:Germany; D006801:Humans; D007052:Ibuprofen / Q000009:adverse effects / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000139:chemically induced / Q000453:epidemiology; D009288:Naproxen / Q000009:adverse effects / Q000627:therapeutic use; D010437:Peptic Ulcer / Q000139:chemically induced / Q000453:epidemiology; D011785:Quality Assurance, Health Care / Q000592:standards*; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors; D009288:Naproxen; D007052:Ibuprofen